The toxicity of tetryl (N-methyl-N,2,4,6-tetranitroaniline) in male and female F344 rats was evaluated after adminstration in the diet for 14 or 90 days. The 14-day study diet concentrations used were 0, 500, 1250, 2000, 2500, and 5000 ppm; the 90-day study diet concentrations were 0, 200, 1000, and 3000 ppm tetryl in the diet. The calculated average daily tetryl intake was 32.1, 82.5, 130.3, 178.9, and 374.4 mg/kg body weight (BW) for females and 31.8, 80.0, 121.0, 170.5, and 349.7 mg/kg BW for males in the 14-day study. For the 90-day studies, the daily tetryl intake was 14.2, 68.8, and 199.0 mg/kg BW for females and 13.0, 62.4, and 179.6 mg/kg BW for males. In the 14-day study, there was a signi® -cant decreasein body weights (males),whereas relative(organ/body weight) liver and spleen (females), and kidney (males) weights were signi® cantly increased in the 5000-ppm dose group. Hematological effects observed were decreased hemoglobin and hematocrit and an increased number of reticulocyts in females (2000 to 5000 ppm). Methemoglobin levels in males (2000 to 5000 ppm) and females (5000 ppm) and total blood protein and albumin levels in all groups of males and females (except 500 ppm) were signi® cantly increased. Histopathological changes were observed in kidneys (deposition of cytoplasmic droplets) of all dose groups of male rats. In the subchronic (90-day) study, feed intake was reduced in all dose groups, but a signi® cant decrease in terminal body weights was observed in females (1000 and 3000 ppm) and males (3000 ppm). An increase in Received 24 March 1998; accepted 18 July 1998. Presentedin part at the Annual Meeting of the Society of Toxicology, Baltimore, MD, March 5±9, 1995.
Tetryl (N -methyl-N ,2,4,6-tetranitroaniline) (CAS #479-45-8) is a nitroaromatic compound that has been used as an explosive in detonators and primers, a detonating agent for other less sensitive, high explosives, and as a booster charge for military devices. Tetryl has been detected in both soil and water in and around military installations and army munition plants where it was manufactured or stored. Erosion and movement through contaminated soils at these sites may release tetryl to surface soil and groundwater (Ryon et al. 1984; Walsh and Jenkins 1992) . Depending on the levels of tetryl, this may pose an unacceptable risk either to humans or to the environment.
Most of the information on health effects of tetryl comes from studies on workers employed in military facilities during the World Wars (Bergman 1952) . Workers that inhaled tetrylladen dust complained of coughs, fatigue, headaches, nosebleeds, nausea, and/or vomiting (Fischer and Murdock 1946) . The most common symptoms reported in workers exposed to tetryl are dermatitis (Probst, Mund, and Lewis 1944; Goh 1984) and gastrointestinal disorders (nausea, anorexia, epigastric pain, vomiting, diarrhea, and constipation) (Troup 1946) . Some workers were more sensitive to tetryl exposure and developed allergies that often included severe asthma-like reactions.
Review of the scienti® c literature on tetryl reveals only a few acute or subchronic toxicity studies. Most of these studies were with small numbers of animals (U.S. EPA 1990). The oral LD50 of tetryl has been reported as greater than 5 g/kg in rats and mice for combined sexes. Tetryl is not a skin irritant to rabbits, but does produce severe eye irritation. On the other hand, tetryl is not a prominent skin sensitizer in guinea pigs (Fitzgerald et al. 1992 ). Recently we have reported on some acute pathological changes (glycogen accumulation in liver and focal coagulative necrosis of gastric mucosa at the junction of stomach and duodenum) and biochemical effects (no changes in content of hepatic microsomal cytochrome P-450 and b5, increase in ethoxy and pentoxy O -dealkylase activities, and no change in cytosolic glutathione S-transferase activity and content of oxidized or reduced glutathione in the liver and testis) of tetryl-dosed rats, 24 hours after a single oral dose (500 or 1000 mg/kg body weight [BW] ) .
The subchronictoxicitydata on tetryl are limited to the study in rabbits (Fati and Daniele 1965) . In this study, one dose (125 mg/ kg) was tested by gavage for 6 months (three rabbits) and 9 months (nine rabbits), resulting in moderate to severe histopathological effects on the liver (hypertrophy, necrosis), kidney (mild congestion, vascular congestion, swollen renal cells), and spleen (congestion, hemosiderin) . Because the toxicity data on tetryl was incomplete, a 90-day study was conducted in rats to examine for possible target organ toxicities and to determine a no observed adverse effect level (NOAEL). Prior to the 90-day study, a 14-day study was conducted to select appropriate doses. These data are required for derivation of a reference dose (RfD) which can be used in health and environmental risk assessments.
MATERIAL AND METHODS

Diet Preparation and Analysis
Tetryl powder, 99.45% purity, was prepared by Dr. W. Koppes of the Naval Surface Warfare Center, Silver Spring, MD. The purity was con® rmed by HPLC analysis at U.S. EnvironmentalProtection Agency (EPA) (Cincinnati, Onio). Certi® ed powdered Purina Laboratory Chow 5002 was purchased (Ralston-Purina Co., St. Louis, MO) and stored at 4 ± C until used. Tetryl diets were prepared weekly as described earlier (Reddy et al. 1994a (Reddy et al. , b, 1996 . The diets were stored at 4 ± C and were found to be stable during the study when analysed by HPLC method. Diet feeders were re® lled twice a week and changed weekly. The homogeneity and concentration of tetryl in each batch of diet prepared was analyzed by extracting the tetryl diet with acetone and was quanti® ed as described (Reddy et al. 1994a, b) .
Animals and Maintenance
Male and female F344 rats, con® rmed free of viral antibodies, pathogenic bacteria, and parasites, were obtained from Charles River Laboratories (Kingston, New York). The animals, 6±7 weeks old and weighing approximately 125 g when delivered, were held for 1 week in quarantine prior to initiation of treatment. The animals were housed in temperature (20±22 ± C)± and humidity (40±60%)±controlledrooms on a 12:12 hour light:dark cycle. During the study, they were housed individually in polycarbonate cages, and food and water were provided ad libitum. Animal identi® cation was accomplished by inserting electronic implants (Bio Medic, Maywood, NJ) and the rats assigned to control and treatment groups according to a computer-generated set of random numbers. The weight variation of the animals used did not exceed § 2 SD of the mean weight at the time of delivery. Animal cages were identi® ed with a color-coded identi® cation card indicating the animal and treatment group. All aspects of the study were conducted in compliance with the guidelines of the American Association for Accreditation of Laboratory Animal Care and according to U.S. EPA Health Effects Testing Guidelines (40 CFR 798), in compliance with Good Laboratory Practice (40 CFR 792).
Fourteen-Day Toxicity Study
Sixty animals were divided into six experimental groups consisting of ® ve males and ® ve females per group. There were ® ve treatment levels of tetryl (0, 500, 1250, 2000, 2500 , and 5000 ppm diet) and a control diet group. All rats were observed daily for physiological and behavioral responses and for morbidity and mortality. Animals were weighed on days 0, 7, and 14. Food and water consumption were measured twice weekly.
Ninety-Day Toxicity Study
One hundred and twenty rats were divided into four experimental groups consisting of 15 males and 15 females per group. Based on the histopathologyand hematology ® ndings of the 14-day study, three treatment levels of tetryl were selected (200, 1000, and 3000 ppm diet) and a control diet group. Five rats from each group were killed on day 45 in order to study hematological and clinical chemistry pro® les, and the remaining 10 were at the termination. All in-life observations and technical procedures were consistent with the 14-day study.
Necropsy and Histopathology
Prior to necropsy, in both the 14-and 90-day studies, the animals were anesthetized with pentobarbital (60 mg/kg BW), and blood samples were collected via cardiac puncture after the body weight was recorded. Following euthanasia via exsanguination, all animals were examined for gross lesions.
During necropsy the following tissues were harvested and weighed: brain, liver, spleen, kidneys, adrenals, lungs, thymus, testes with epididymides, ovaries, and heart. In addition to these tissues, various other tissues were also examined (Reddy et al. 1994b ) and preserved in 10% neutral-buffered formalin. Subsequently, tissues were trimmed, processed, and embedded in paraf® n blocks and were sectioned at 5 l m. Microscopic slides were prepared and stained with hematoxylin and eosin. Selected kidney sections were stained with mallory-heidenhain stain and immunohistichemistry was performed for alpha-2-microglobulin with standard. All tissues were examined in the high-dose and control groups of both sexes, with target organs (spleen, kidney, and testes) being examined in the remaining groups.
In¯ammatory and degenerative lesions were graded according to severity using a scale of 1 to 4 (minimal, mild, moderate, or marked). Data were tabulated according to individualanimal and summarized by group. In addition, gross observations and microscopic diagnoses were correlated for each animal. LABCAT (Innovation Programming, Inc., Princeton, NJ) histopathology software was used for data management.
Hematology and Clinical Chemistry
Hematology parameters were assessed using a Serono-Baker Hematology Analyzer Model 9000 (Serono-Baker, Allentown, PA) coupled to a personal computer running LABCAT software. Total red and white blood cell counts, platelet count, differential leukocyte count, hemoglobin, packed cell volume, and reticulocytes were measured and computed. Methemoglobinlevels were determined on a IL 482 Co-Oximeter (Instrumentation Laboratory Co., Lexington, MA).
Clinical chemistry parameters were measured using a COBAS Fara II centrifugal analyzer (Roche, Nutley, NJ) with a nonselective electrode (ISE) module interfaced with a personal computer and the LABCAT software system. Clinical chemistry analytes for the study included sodium, potassium, total protein, albumin, calcium, phosphorus, total bilirubin, blood urea nitrogen, creatinine, alanine aminotransferase, aspartate aminotransferase, glucose, alkaline phosphatase, triglycerides, and cholesterol.
Opthalomological Examination
In the 90-day study,all animals were examinedprior to the initiation of the study and after study by a board-certi® ed veterinary pathologist for any abnormalities. The examinations included are (a) biomicroscopic examination, using a Zeiss HSO-10 biomicroscope, and (b) indirect opthalmoscopic examination. 
Statistical Evaluation
Males and females were considered separatelyin all statistical analyses.A one-factor (dose) analysis of variance (ANOVA) was used to analyze normally distributed measures: body weights, organ weights, organ weight ratios, food and water consumption, hematology and clinical chemistry. When a treatment effect was noted ( p · .05, F test), the difference between the control and the treatment groups was probed using a multiple comparison procedure (Dunnett's t test) (Dunnett 1964) .
RESULTS
Fourteen-Day Toxicity Study
There was no mortality, no evidence of overt toxicity, and no treatment-related effects on either water or food consumption. However body weights in the high-dose (5000 ppm) male group were signi® cantly decreased. Based on the food consumption data, the average daily dose levels of tetryl consumed (mg/kg BW) were 32.1, 82.5, 130.3, 178.9, and 374.4 for females and 31.8, 80.0, 121.0, 170.5, and 349.7 for males (Table 1) .
There were no changes in absolute organ weights in males and females (data not shown), but mean relative organ weights (to ® nal body weight) for female and male rats were signi® -cantly different from control (Table 2 ). There was a signi® cant increase in relative weight of liver (at 2500 and 5000 ppm) and spleen (5000 ppm) of female and liver and kidney (5000 ppm) of male rats. The other organs, such as heart, brain, lungs, thymus, ovaries, and testes, showed no apparent changes in weights compared with other dose groups (data not given).
Hematology and Clinical Chemistry
The effects of tetryl on hematological parameters of the 14-day study are presented in Table 3 . Female rats exhibited signi® cantly decreased hemoglobin (2000 and 5000 ppm), hematocrit (2000 ppm), and increases in the number of reticulocytes (2000 and 2500 ppm). None of these parameters were signi® -cant in males except for an increase in reticulocytes (2000 ppm). Percent methemoglobin was increased in males (2000, 2500, and 5000 ppm) and females (5000 ppm). The results of the clinical chemistry analyses are summarized in Tables 4 and 5 . The mean serum protein and albumin levels were signi® cantly increased in all dose groups except for females receiving 500 ppm. Calcium was signi® cantly increased in males (500 and 1250 ppm), whereas total bilirubin was increased in females (2000, 2500, and 5000 ppm). Alkaline phosphatase was signi-® cantly decreased in all male groups except the 500-ppm group whereas sodium was decreased only in females (5000 ppm). Other clinical parameters such as phosphorus, blood urea nitrogen (BUN), creatinine, aspartate aminotransferase, alanine aminotransferase, and potassium are within normal limits (data not given) (Reddy et al. 1994a) .
Histopathology
Histopathological analysis of all tissues of both sexes revealed only one signi® cant change, the increased incidence of cytoplasmic droplets in proximal renal cortical tubular epithelial cells of male rats. This change was noted at all dose levels. These droplets stained positive for protein using a Mallory-Heidenhain stain (not shown). All other diagnoses were considered spontaneous because their incidence and severity levels were low.
Ninety-Day Toxicity Study
In-Life Observations
There were no early deaths or other clinical signs of toxicity at any dose level. Food consumption was signi® cantly reduced in all dose groups of both sexes, whereas water consumption was increased in females receiving 3000 ppm (Table 6 ). Using the food consumption data, the average daily dose of tetryl consumed (mg/kg BW) were 14.2, 68.8, and 199.0 for females and 13.0, 62.4, and 179.6 for males. Terminal body weights were decreased in males (3000 ppm) and the female 1000-and 3000-ppm groups (Table 7) . 
Organ Weights and Ratios
Absolute spleen weights increased in males; however, the relative spleen weights were increased signi® cantly in both sexes at 3000-ppm dose groups (data on absolute organ weights are not given) (Reddy et al. 1994b ). The absolute brain weights were decreased in males (3000 ppm) and in females (1000 and 3000 ppm). The absolute adrenal weights in the 1000-ppm female group were also decreased. In addition,the absoluteadrenal and thymus weights were also decreased in the 3000-ppm diet groups. Relative organ weights are presented in Table 7 . There was no change in absolute kidney weights of male and female rats of all dose groups; however, a signi® cant increase in relative kidney weight was evident in all treatment groups of both sexes except for the male 200-ppm group. Absolute and relative liver weights were increased in both sexes receiving 3000 ppm whereas in the 1000-ppm group, only the relative liver weights were increased in both males and females. 
Hematology and Clinical Chemistry
Hematologicalanalyses are presented in Table 8 . A treatmentrelated decrease was observed in red blood cell counts and hemoglobin levels, whereas increased platelets, percent reticulocytes, and percent methemoglobin were noted in both sexes receiving the 3000-ppm diet. Males in this same group had a decreased hematocrit. Animals receiving the 1000-ppm diet exhibited decreased hemoglobinlevel and increased percent methemoglobin in both sexes. For males the hematocrit values were decreased whereas in females increased platelet and reticulocyte counts were seen.
TABLE 7
Effect of tetryl on terminal body weights and organ-to-body weight ratios after 90 days Tables 9 and 10 . In the 3000-ppm group, both sexes had signi® -cantly increased levels of total protein, albumin, total bilirubin, and cholesterol, whereas alkaline phosphatase was decreased. Also in this same group, males had increased calcium levels whereas females showed decreased triglyceride values.
The 1000-ppm group of both sexes displayed signi® cantly increased levels of total protein, albumin, bilirubin, and cholesterol, whereas only males had increased calcium and blood urea nitrogen. Females in this same group had an elevated glucose value whereas males had a decreased alkaline phosphatase. In the 200-ppm group both sexes had signi® cantly increased cholesterol and total bilirubin levels, whereas females had increased aspartate aminotransferase and albumin levels. Males in this same group had a decreased alkaline phosphatase level. All these values were within normal range for F344 rats and considered not biologically signi® cant.
Ophthalmology Findings
All animals used in this study were affected with mild corneal dystrophy prior to the initiation of the study, which is a common ® nding in Fischer 344 rats of both sexes. During the study
FIGURE 1A
Spleen from control male rat. H&E. (£ 400).
interval, corneal dystrophy lesions did not progress except in one animal. The remaining abnormalities were sporadic and did not appear to be a dose-related effect. Tetryl did not effect the eyes of rats.
Histopathology
Spleens were characterized in both sexes in the 3000-ppm dose group by prominent deposition of intra-and extracellular pigment (probable hemosiderin). Males also showed excessive erythroid cell hyperplasia in the same dose group ( Figure 1A, B) .
FIGURE 1B
Spleen from high dose (3000 ppm). Note increase in erythroid hematopoietic cells (arrow and pigment H&E. (£ 400)).
FIGURE 2A
Renal cortex from control male rat. H&E. (£ 400).
The renal cortical epithelium of both sexes showed pigment deposition in the 1000 and 3000 ppm diet groups. Kidneys in males were further characterized by a dose-related increased severity of tubular degeneration and regeneration, hyaline casts, and cytoplasmic droplets in proximal cortical tubular epithelial cells (Figure 2A, B) . These droplets stained positively for protein (Mallory-Heidenhain stain) (Figure 3 ) and also characterized immunohistochemically as alpha-2-microglobulin.The remaining diagnoses were considered spontaneous because their incidence or severity levels were low.
FIGURE 2B
Renal cortex from male rats (3000 ppm tetryl) diet. Note prominent droplets in tubular epithelium (arrows). H&E.
(£ 400).
FIGURE 3
Mallory-Heidenhain stain of renal cortex from high dose (£ 400).
DISCUSSION
Information on the toxicity of tetryl is limited to a few acute toxicity studies (U.S. EPA 1990; Reddy et al. 1997) . Observed toxic effects of tetryl in subacute and subchronic toxicity studies have includedchangeshematological,renal, splenic, and hepatic organs. These effects are similar to the target organ toxicity of other nitroaromatic compounds such as nitrobenzenes (Bond et al. 1991; Cody et al. 1981; Blackburn et al. 1988; Chandra et al. 1995 Chandra et al. , 1997a Reddy et al. 1996 Reddy et al. , 1998 and nitrotoluenes (Levine et al. 1983 Furedi et al. 1984; Rickert 1985) .
Feed consumption was not altered in any group during the 14 days of tetryl administration. However, exposure for 90 days revealed signi® cant decreases in feed consumption for all dose levels in both sexes. However, the ® nal body weights were decreased in the 14-day study in males (5000 ppm) and in the 90-day study in males (3000 ppm) and females (1000 and 3000 ppm). The decrease in feed consumption at lowest dose (200 ppm) did not change the body weights of rats of both sexes in the 90-day study.
Relative organ weights such as those of liver and kidneys (1000 and 3000 ppm) and spleen (3000 ppm) were signi® cantly increased in both sexes after 90 days' tetryl exposure. There was no change in absolute kidneys weights of male and female rats of all dose groups; however, the relative kidney weights of both sexes were increased except for males (200 ppm). Histopathology analysis revealed that there were no treatmet related lesions in females (all doses) and males (200 ppm).
Tetryl produced hemopoietic effects in rats in 14-day (2000 to 5000 ppm), 45-day (data not given) (see report, Reddy et al. 1994b) ,and 90-day studies (1000 and 3000 ppm). These hematopoietic changes typi® ed a regenerative anemia delineated by a decreased red blood cell count, hematocrit, and hemoglobin levels, and an increased reticulocyte count). In addition, splenic weights were increased and were accompanied by a prominent erythroid cell hyperplasia. Methemoglobin concentrations were signi® cantly increased (1000 and 3000 ppm) in the 90-day study. Tetryl produced hematological and liver effects, 24 hours after a single oral dose (500 and 1000 mg/kg BW) in rats . Similar ® ndings regarding anemia were also noted in amunition workers exposed to TNT (Hathaway 1977) and in animal studies involving 1,3-dinitrobenzene (Cody et al. 1981 ), 1,3,5-trinitrobenzene (Chandra et al. 1995; Reddy et al. 1996 Reddy et al. , 1997 and TNT (Levine et al. 1983 Furedi et al. 1984) .
Selective clinical chemistry analytes were altered in both the 14-and 90-day studies. Bilirubin was signi® cantly increased due to the prominent amount of erythrocyte damage in low-and high-dose group of females and all dose groups of male, but the increase was not dose related. Bilirubin is the reduced form of biliverdin, which has been reduced from the heme molecule of hemoglobin. Serum proteins (which include albumin) were also increased in many of the same exposure groups, this may be due to renal changes.
Even though changes in several of the clinical chemistry analytes were statistically signi® cant in the low-dose group (200 ppm), they were not considered biologicallymeaningful because their values were within an accepted normal reference range (Dr. J. Mcgrath, Eli Lilly, personal communication; NTP 1990; our laboratory historical data). Clinical chemistry values are usually more elusive. We assumed these changes are not detrimental to animals and can be changed or compensated for over the animals' life span, and they are considered as a no adverse effect level for derivation of RfD. Nitroaromatic compounds such as nitrobenzene, 1,3-dinitrobenzene, and 1,3,5-trinitrobenbene produced testicular effects (decreased size and weight and degeneration of seminiferous tubules) in rats (Blackburn et al. 1988; Chandra, Qualls, and Reddy 1997a, b; Reddy et al. 1996 Reddy et al. , 1997 . This was not apparent with tetryl at any dose level in either study, suggesting the testis is not a target organ for toxicity of tetryl.
The deposition of cytoplasmic droplets was noted in cortical renal tubules of male rats in all dose groups (500 to 5000 ppm) in the 14-day study and in the 1000-and 3000-ppm dose groups of the 90-day study. These droplets stained positively for protein, suggesting that tetryl may be binding to a nonspeci® c urinary protein. The resulting tetryl-protein complex was more resistant to proteolytic degradation by liposomal enzymes and produced protein overload in renal cortical tubules (Loury, Smith-Oliver, and Butterworth 1987) . This protein overload was not signi® cantly detrimental to the kidneys in the 90-day study and was cleared with time. Hyaline droplets containing alpha-2±microglobulin in proximal tubules were reported in male rats treated with 1,3,5-trinitrobenzene (Reddy et al. 1996 (Reddy et al. , 1998 Kim et al. 1997) . Hyaline droplet accumulation in proximal tubule has been observed in male rats exposed to gasoline, 2,2,4-trimethylpentane, decaline, 1,4-dichlorobenzene, pentachlorobenzene, and d-limonene. This protein is not found in humans (Hard et al. 1993 ) and considered not relevant in human health risk assessment.
Tetryl is a compound of limited occurrence and use, and thus limited exposure possibilities.Nevertheless, questions regarding its risk have arisen in places where it does occur. It is important to have a credible toxicity database on this compound. Thus based on the results of this study, we suggest that the NOAEL for tetryl should be considered to be 13 mg/kg BW/day (combined sexes). We calculateda subchronic RfD of 0.13 mg/kg/day based on the results of this study and using an uncertainty factor of 100 (from animal to human, 10; human sensitive population, 10). This value is in agreement with the reported provisional subchronic RfD value 0.12 mg/kg/day based on a single oral dose level of a low observed adverse effect levels (LOAEL) of 125 mg/kg BW/day in rabbits (9 animals) for 9 months (U.S. EPA 1990).
